Investment Firms Begin Coverage of Complete Genomics
December 21, 2010
Investment Firms Begin Coverage of Complete Genomics
R.W. Baird, the Cowen Group, Jefferies, and UBS each recommended Complete Genomics' stock with target share prices significantly above the company's current trading price.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Jefferies Restarts Coverage of Complete Genomics with 'Buy' Rating
June 6, 2011 / GenomeWeb Daily News - William Blair Initiates Coverage of PacBio, Complete Genomics
April 19, 2011 / GenomeWeb Daily News - Investment Firm Jefferies Resumes Coverage on Eight MDx, Genetic Testing, Tools Firms
March 11, 2011 / GenomeWeb Daily News - Mizuho Initiates Coverage of Complete Genomics with Outperform Rating
September 15, 2011 / GenomeWeb Daily News - Paired Ends: William Rastetter, Ajay Bansal
April 2, 2013 / In Sequence